Gary V. Cantrell

Accentia Biopharmaceuticals, Inc. engages in the commercialization of patent-protected disruptive healthcare technologies. It offers products under the BiovaxID., Revimmune, and SinuNase brands. The company was founded in 2002 and is headquartered in Tampa, FL.

The Catevo Group, Inc. provided business consulting services. It offered strategic marketing, integrated communications, consulting and technology solutions. The company was founded in 2006 and was headquartered in Raleigh, NC.

TEAMM Pharmaceuticals, Inc. engaged in the business of selling prescription based pharmaceutical products. The company was headquartered in Morrisville, NC.

GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada.

Vyrix Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It maximizes the clinical and commercial potential of its late-stage sexual dysfunction products. The company is currently focused on advancing the development of Zertane™ for Premature Ejaculation (PE) in the US and around the world. Vyrix Pharmaceuticals was founded on November 18, 2013 and is headquartered in Greenwood Village, CO.

Flexible Stenting Solutions, Inc. manufactures and distributes medical devices. It develops third-generation flexible peripheral arterial, venous, neurovascular and biliary stents. The company was founded by Janet W. Burpee in 2006 and is headquartered in Eatontown, NJ.